opsoclonus myoclonus syndrome oms also known opsoclonusmyoclonusataxia oma rare neurological disorder unknown cause appears result autoimmune process involving nervous system extremely rare condition affecting people per year affects children neuroblastoma reported occur celiac disease diseases neurologic autonomic symptoms includecitation needed half oms cases occur association neuroblastoma cancer sympathetic nervous system usually occurring infants cases oms starts acute flareup physical symptoms within days weeks less obvious symptoms irritability malaise may begin weeks months earliercitation needed children cases associated neuroblastoma others suspected associated lowgrade neuroblastoma spontaneously regressed detection adults cases associated breast carcinoma smallcell lung one paraneoplastic meaning indirectly caused cancer syndromes occurs children adults although mechanism immune dysfunction underlying adult syndrome probably quite differentcitation needed hypothesized viral infection perhaps st louis encephalitis chikungunya epsteinbarr coxsackie b enterovirus flu causes remaining cases though direct connection rare cases opsoclonus myoclonus syndrome associated lyme disease also oms generally considered infectious disease oms passed geneticallycitation needed oms rare occurs average age months months diagnosis slow cases diagnosed caused virus diagnosis oms made associated neuroblastoma discovered half cases median delay interictal eeg pattern usually known definitive cure oms however several drugs proven effective treatment medication used treat symptoms national organization rare disorders nord recommends flair therapy consisting threeagent protocol involving frontloaded highdose acth ivig rituximab developed national pediatric myoclonus center bestdocumented almost patients show improvement treatment relapse rate appears detailed summary current treatment options found treatment options following medications probably avoided currently clinically established laboratory investigations available predict prognosis therapeutic responsecitation needed tumors children develop oms tend mature showing favorable histology absence nmyc oncogene amplification similar tumors children without symptoms involvement local lymph nodes common children rarely distant metastases prognosis terms direct morbidity mortality effects tumor threeyear survival rate children nonmetastatic neuroblastoma oms according childrens cancer group data gathered patients diagnosed threeyear survival comparable patients oms although symptoms oms typically steroidresponsive recovery acute symptoms oms quite good children often experience lifelong neurologic sequelae impair motor cognitive language behavioral children experience relapsing form oms though minority monophasic course may likely recover without residual viral infection may play role reactivation disease patients previously experienced remission possibly expanding memory b cell studies generally asserted children oms longterm neurologic cognitive behavioral developmental academic impairment since neurologic developmental difficulties reported consequence neuroblastoma treatment thought exclusively due immune mechanism underlying one study concludes patients oma neuroblastoma excellent survival high risk neurologic sequelae favourable disease stage correlates higher risk development neurologic sequelae role antineuronal antibodies late sequelae oma needs another study states residual behavioral language cognitive problems occurred national institute neurological disorders stroke ninds conducts supports research various movement disorders including opsoclonus myoclonus studies focused finding ways prevent treat cure disorders well increasing knowledge oms first described marcel kinsbourne term opsoclonus coined orzechowski classically described associated neuroblastoma kinsbourne names oms includecitation needed httpsenwikipediaorgwikiopsoclonusmyoclonussyndrome